BullBD Old Apps Site
Home
Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

SQURPHARMA

All Eps Dividend Board Agm Q1 Q2 Q3

SQURPHARMA 01-Feb-2015

(Q3 Un-audited): Consolidated profit after tax (excluding non controlling interest) from Oct'14 to Dec'14 was Tk. 1,527.92 million with consolidated EPS of Tk. 2.76 as against Tk. 1,508.31 million and Tk. 2.72 respectively for the same period of the previous year. Whereas consolidated profit after tax from Apr'14 to Dec'14 was Tk. 4,220.59 million with consolidated EPS of Tk. 7.61 as against Tk. 4,104.82 million and Tk. 7.41 respectively for the same period of the previous year.

SQURPHARMA 02-Feb-2014

(Q3): As per un-audited quarterly accounts for the 3rd quarter ended on 31st December 2013 (Oct'13 to Dec'13), the Company has reported consolidated profit after tax (excluding non controlling interest) of Tk. 1,589.34 million with consolidated EPS of Tk. 3.30 as against Tk. 1,194.34 million and Tk. 2.48 respectively for the same period of the previous year. Whereas consolidated profit after tax (excluding non controlling interest) was Tk. 4,104.82 million with consolidated EPS of Tk. 8.52 for the period of nine months (Apr'13 to Dec'13) ended on 31.12.2013 as against Tk. 3,245.10 million and Tk. 6.73 respectively for the same period of the previous year.

Previous Next page